logo

Last Update

This profile was last updated on 3/8/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Robert Fildes?

Robert A. Fildes

Director

La Jolla Pharmaceutical Company

HQ Phone:  (858) 207-4264

Direct Phone: (403) ***-****direct phone

Email: r***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

La Jolla Pharmaceutical Company

10182 Telesis Court 6Th Floor

San Diego, California,92121

United States

Company Description

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The company has ...more

Background Information

Employment History

CelaCare Technologies LLC


Affiliations

SB2

President


Inimex Pharmaceuticals Inc.

Director


CM Capital Investments

Executive Advisor


inimexpharmaceuticals.com

Board Member


CIBA Vision Corporation

Board Member


Royal Canadian Bank

Member of the Investment Committee


Carrington Laboratories , Inc.

Board Member


HiQSoft Business Solutions

Board Member


Industrial Biotechnology Association

Founder and Board Member


Haas School of Business

Member of the School of Business Advisory Board


Association of Biotechnology Led Enterprises

Board Member


Education

B.Sc.

chemistry and human physiology

University of London


D.C.C. degree

Microbial Biochemistry

University of London


PhD

Biochemical Genetics

University of London


Web References(65 Total References)


celacare-people

www.celacare.com [cached]

Dr. Robert Fildes, a biotechnology industry veteran who previously served as president, and/or CEO of Cetus Corporation, Scotgen Biopharmaceuticals, Atlantic Pharmaceuticals and Biogen Inc., and as a senior executive at Bristol Myers Squibb and GlaxoSmithKline, will also serve as an advisor to the company.
Currently he serves as president of SB2, Inc. and as a director of Inimex Pharmaceuticals, Inc. and La Jolla Pharmaceutical Company. Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry and a Ph.D. in Biochemical Genetics from the University of London.


Investor Relations - Directors & Management Team

www.ljpc.com [cached]

Robert A. Fildes, Ph.D.
Robert A. Fildes, Ph.D. President, SB2, Inc. Robert A. Fildes, Ph.D. has been a director since 1991. Since January 1998, Dr. Fildes has served as President of SB2, Inc., a privately held company that licenses antibody technology. From June to December 1998, Dr. Fildes served as Chief Executive Officer of Atlantic Pharmaceuticals, a publicly held company in the field of biotechnology. From 1993 to 1997, Dr. Fildes was the Chairman and Chief Executive Officer of Scotgen Biopharmaceuticals, Inc., a privately held company in the field of human monoclonal antibody technology. From 1990 to 1993, Dr. Fildes was an independent consultant in the biopharmaceutical industry. He was the president and Chief Executive Officer of Cetus Corporation, a publicly held biotechnology company, from 1982 to 1990. From 1980 to 1982, Dr. Fildes was the President of Biogen, Inc., which merged with IDEC Pharmaceuticals Corporation in 2003 to form Biogen Idec, a publicly held biopharmaceutical company, and from 1975 to 1980, he was the Vice President of Operations for the Industrial Division of Bristol-Myers Squibb Company. From April 2002 to April 2003, Dr. Fildes was a director of Polymerat Pty. Ltd. (now Bio-Layer Pty. Ltd.), a privately held company that develops surfaces for carrying out biological reactions. Dr. Fildes is currently a director of Inimex Pharmaceuticals, Inc., a privately held Canadian biotechnology company. Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry and a Ph.D. in Biochemical Genetics from the University of London.


Investor Relations - Directors & Management Team

www.ljpc.com [cached]

Robert A. Fildes, Ph.D.
Robert A. Fildes, Ph.D. President, SB2, Inc. Robert A. Fildes, Ph.D., 64, has been a director of the Company since 1991. Since January 1998, Dr. Fildes has served as President of SB2, Inc., a privately held company which licenses antibody technology. From June to December 1998, Dr. Fildes served as Chief Executive Officer of Atlantic Pharmaceuticals, a publicly held company in the field of biotechnology. From 1993 until August 1997, Dr. Fildes was the Chairman and Chief Executive Officer of Scotgen Biopharmaceuticals, Inc., a privately held company in the field of human monoclonal antibody technology. Scotgen Biopharmaceuticals filed for Chapter 7 bankruptcy protection under the federal bankruptcy laws in August of 1997. From 1990 to 1993, Dr. Fildes was an independent consultant in the biopharmaceutical industry. He was the President and Chief Executive Officer of Cetus Corporation, a publicly held biotechnology company, from 1982 to 1990. From 1980 to 1982, Dr. Fildes was the President of Biogen, Inc., a publicly held biopharmaceutical company, and from 1975 to 1980, he was the Vice President of Operations for the Industrial Division of Bristol-Myers Squibb Company. Dr. Fildes is currently a director of Cytovax Biotechnologies, Inc., a publicly held company that develops and commercializes vaccines and therapeutic products for the prevention and treatment of infectious diseases. Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry and a Ph.D. in Biochemical Genetics from the University of London.


Twinstrand Therapeutics

www.twinstrand.com [cached]

Robert A Fildes, PhD, Chair
Former President & CEO, Cetus Corporation Former President, Biogen Inc. Dr. Fildes is currently a director of La Jolla Pharmaceutical Company (a public American biotechnology company) and Chairman of Inimex Pharmaceuticals Inc. (a private Canadian biotechnology company). He has more than 30 years of experience in the biotechnology and pharmaceutical industry. Dr. Fildes has served as Chairman & CEO of Scotgen Biopharmaceuticals Inc., President & CEO of Cetus Corporation, and President of Biogen Inc. He spent 15 years as a senior manager in big pharmaceutical companies, first with GlaxoSmithKline and then as Vice President of Operations for the Bristol-Myers Squibb Company. Dr. Fildes holds a DCC degree in Microbial Biochemistry and a PhD in Biochemical Genetics from the University of London.


celacare-people

celacare.com [cached]

Dr. Robert Fildes, a biotechnology industry veteran who previously served as president, and/or CEO of Cetus Corporation, Scotgen Biopharmaceuticals, Atlantic Pharmaceuticals and Biogen Inc., and as a senior executive at Bristol Myers Squibb and GlaxoSmithKline, will also serve as an advisor to the company.
Currently he serves as president of SB2, Inc. and as a director of Inimex Pharmaceuticals, Inc. and La Jolla Pharmaceutical Company. Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry and a Ph.D. in Biochemical Genetics from the University of London.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory